Equity Research, Broker Reports, and media content on ISHR GVT GERMANY 2 5-5 5 DE

  • Access the latest forecasts, broker valuations, multiples, and video content from the city about ISHR GVT GERMANY 2 5-5 5 DE
  • See live updates from analysts, company announcements, and other news in a personalised/single dashboard

Research, Charts & Company Announcements

Research Tree provides access to ongoing research coverage, media content and regulatory news on ISHR GVT GERMANY 2 5-5 5 DE. We currently have 0 research reports from 0 professional analysts.

Open
N/A
Range Today
N/A
52 Week
0.00/0.00
Daily Volume
N/A
# Shares
0m
Daily Liquidity
0.0%
Pension Liability
Enterprise Value
n/am
Market Cap
0m
Latest PE (hist)
Div Yield

Latest News/RNS

(more news)
Date Source Announcement
Get free RNS email alerts

  • Frequency of research reports

     

  • Research reports on

    ISHR GVT GERMANY 2 5-5 5 DE

  • Providers covering

    ISHR GVT GERMANY 2 5-5 5 DE

  • 27 Jan 20
Cenkos: Equals Group Plc -- Strong growth confirmed with B2B pivot

Today's update confirms Equals has delivered a second straight year of material revenue and profit growth, despite difficult market conditions, with a significant shift in the revenue profile towards more profitable B2B customers. Given profit delivery has been slightly lower than expected, we rebase our forecasts to take a more prudent view of trading in years FY21E and FY22E, but we are confident Equals has now assembled the products, infrastructure and management it needs for strong growth.

Companies: Equals Group
  • 22 Jan 20
LIBERUM: NewRiver* - A resilient operating performance shows not all retail is the same

NewRiver's Q3 update confirms a resilient operating performance in a tough market overall, which should provide reassurance. Retail occupancy increased through Q3 to 96.1%, with lettings agreed 3% ahead of ERV.

Companies: Newriver Reit
  • 22 Jan 20
Asset Owner, asset manager

The demerger of Prudential has given birth to the third largest UK asset manager, M&G plc. With an important book of Life insurance products, mainly in its Heritage business unit, M&G should be able to cope with the low interest rates context. However, the company should benefit from the slow run-off profile of its business to generate stable operating earnings and cash flows. The focus will be given to Asian and US growth. We begin our coverage with an Add opinion.

Companies: M&G
  • 22 Jan 20
Record - Positive AUME flows and performance fees

Record’s Q320 update was positive, with a 4% inflow of assets under management equivalent (AUME) and the crystallisation of a performance fee in the period. AUME flows have now been positive since Q120, totalling $4.5bn (+8%) over nine months. The performance fees in this quarter follow on from a material contribution during FY19, reflecting value added for clients. Record continues to innovate and invest to counter competitive pressure, which has contributed to broadly stable management fee rates.

Companies: Record
  • 08 Jan 20
UK Housebuilding Sector: 2020 vision: Sharpness and clarity for industry prospects

For fighter pilots, it is a minimum requirement. But having 20/20 ‘visual acuity’ (correct term) does not necessarily mean you have perfect vision (as convention assumes); instead, it indicates sharpness and clarity of vision at a distance. It is measured by a Snellen Chart, which displays letters of progressively smaller size and whereby 20/20 means that the test subject sees the same line of letters at 20 feet that a person with normal vision sees at 20 feet (or 6 metres; but 6/6 simply didn’t catch on).

Companies: ABBY BDEV BWY BKG VTY CRN CSP CRST GLE GLV INL MCS PSN RDW SPR TW/ WJG

  • 21 Jan 20
LIBERUM: Harworth* - Solid operational performance in H2

Harworth reports a period of a solid operational performance in H2 2019, which together with the indicative independent valuation means the principal performance measure NNNAV is expected to be in line with expectations. Progress has been made across each business area, but planning headwinds remain a key challenge.

Companies: Harworth Group
  • 21 Jan 20
Cenkos: MJ Hudson Group Plc -- The Best Alternative

MJ Hudson (MJH) is a financial services infrastructure platform business. The company is capitalising on the shift in the asset management industry to alternative investments, and filling a vacuum left by banks withdrawing their support for the sector in the aftermath of the global financial crisis. We estimate MJH's fair value to be up to c30% higher than its current share price, noting that the peer group has performed strongly since the company's IPO. We initiate with a Buy recommendation.

Companies: MJ Hudson Group
  • 24 Jan 20
European Assets Trust - Long-term capital growth and income

European Assets Trust (EAT) aims to generate long-term capital growth through investing in quoted small- to medium-sized companies in Europe, excluding the UK. Over the past 10 years, EAT’s NAV total return (TR) has generated an annualised return of 12.9%. The board has a high payout policy and a 17.2% increase in the declared FY20 dividend results in a forward yield of 6.6%. Previously dual-listed in Amsterdam and London, EAT completed its legal migration to the UK in March 2019. The board believes a premium listing on the London Stock Exchange and becoming a constituent of the FTSE SmallCap and FTSE All-Share indices could broaden EAT’s appeal and help close the trust’s NAV discount over time.

Companies: European Assets Trust
  • 21 Oct 19
Quarterly Research Outlook Autumn 2019

Following continued delays of a Brexit agreement, few sectors within the UK market have remained attractive to investors despite low valuations. One sector which has continued to outperform despite the political drama has been the UK video gaming sector (henceforth UK gaming), which we are fans of. We believe a combination of sector-leading growth, strong cash conversion and timely cyclical positioning support our positive view on the UK video gaming sector.

Companies: ABBY AMS ANX ARS ATYM AVON BLVN PIER BUR CGS CAML CDM CSRT TIDE CYAN DTG DEMG ELM EMR FPO FDEV GTLY GENL GHH GRI GEEC GKP HMI HAYD HEAD HILS HTG HUR IBPO IOG INDI JHD JOG KAPE KEYS KWS KCT KGH LAM LIT LOK MACF MANO MOD OXIG PCA PANR APP SRE PHC PMO RBW RMM RBGP REDD RSW RNO ROR SUS SCPA SEN SHG SOLG SOM SUMO TM17 INCE TWD TRAK TRI VNET VTC ZOO ZTF

  • 22 Jan 20
LIBERUM: Alternatives Daily: PSSL | CLOs

Pollen Street Secured Lending - Manager recommends 25% dividend increase CLO Funds - Positive end to a volatile 2019

Companies: Pollen Street Secured Lending
  • 24 Jan 20
Acorn Income Fund - Small-cap growth backed by c 5% yield

Acorn Income Fund (AIF) saw a significant bounce back in performance during 2019, boosted by greater clarity on Brexit following December’s general election. In what was also a good year for the operational performance of companies in AIF’s small-cap portfolio (c 77% of assets), the fund ended the year with an NAV total return of 27.4%. This was ahead of the benchmark and more than made up for losses in 2018, meaning the fund has also regained its medium- and longer-term record of outperformance. While the smaller companies managers (Simon Moon and Fraser Mackersie at Unicorn Asset Management) are very positive on the prospects for both capital and income in the year ahead, the income portfolio managers (Chun Lee and Robin Willis at Premier Miton) are less sanguine, and remain focused on absolute returns as a result.

Companies: Acorn Income Fund
  • 24 Jan 20
The Biotech Growth Trust - Positive outlook for 2020

The Biotech Growth Trust (BIOG) is managed by Geoff Hsu and Richard Klemm at OrbiMed Capital. They remain optimistic about the prospects for the sector in 2020 due to high levels of innovation and a relaxed regulatory environment, while a continuation in merger and acquisition (M&A) activity would also likely provide further support for biotech shares. The managers are very encouraged by the trust’s much-improved investment performance in recent months, noting they are being rewarded by the market for their in-depth fundamental research and portfolio positioning in favour of emerging rather than large-cap biotech stocks. BIOG’s NAV has now outperformed the NASDAQ Biotechnology index benchmark over the last one, three, five and 10 years.

Companies: The Biotech Growth Trust
  • 27 Jan 20
Capital Access' Hot Off The Wires - The Day Ahead

Our Hot Off The Wires daily newsletter takes a look at the morning's market movements, news stories and company announcements. Don't forget to have a go at our daily trivia! Companies mentioned in this edition include:AstraZeneca, Halma, TI Fluid Systems, ITM Power, Gresham House, *Randall & Quilter, Shield Therapeutics, H&T Group, Begbies Traynor and the potential upcoming IPO of Cabot Square Alternatives. If you would like to be subscribed, please email us at info@capitalaccessgroup.co.uk. *Capital Access represents Randall & Quilter - if you would like more information or access to the Management team of this company, please get in touch.

Companies: Randall & Quilter Investment
  • 27 Sep 19
Cenkos: Equals Group Plc - Equals = a broader business these days

Equals has continued to produce high rates of YoY growth over H1/19A and thereafter, despite macroeconomic events negatively impacting on consumer/business confidence. We consider this reflects the increasing breadth and strength of the business, moving away from its consumer FX roots with increasingly product, customer and geographical diversity driving growth, aided by supply chain rationalisation. We see these steps advancing Equals into an integrated money manager fit for the future.

Companies: Equals Group
  • 22 Jan 20
LIBERUM: Harworth* - Near term planning headwinds but latent potential remains strong

Harworth reported a period of solid operational performance in H2 2019, which together with the indicative independent valuation means the principal performance measure NNNAV is expected to be in line with expectations. Whilst good progress has been made during the period across each business area, planning headwinds remain a key challenge.

Companies: Harworth Group